DICE Therapeutics Inc. (DICE)
NASDAQ: DICE
· Real-Time Price · USD
47.55
0.03 (0.06%)
At close: Aug 08, 2023, 10:00 PM
DICE Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -15.78 | -17.14 | -15.67 | -9.53 | -6.67 | -9.59 | -14.52 | -3.57 | -42.98 | -26.56 |
PEG Ratio | -0.21 | 1.07 | 2.77 | 1.11 | -0.42 | -0.7 | 0.18 | -0.00 | 1.07 | -1.9 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.13K | n/a |
PB Ratio | 4.23 | -6.34 | -7.56 | 2.91 | 2.09 | 2.41 | -9.07 | 0.76 | -18.65 | n/a |
P/FCF Ratio | -72.29 | -59.73 | -77.33 | -47.96 | -32.52 | -48.99 | -64.38 | -27.34 | -158.36 | -102.45 |
P/OCF Ratio | -76.92 | -60.26 | -79.22 | -49.6 | -34.23 | -50.33 | -65.25 | -27.71 | -159.08 | -107.12 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.07 | n/a |
Debt / Equity Ratio | 0.02 | -0.06 | -0.07 | 0.05 | 0.05 | 0.06 | -0.02 | 0.01 | -0.03 | n/a |
Quick Ratio | 25.88 | 32.44 | 38.14 | 22.96 | 23.61 | 20.75 | 29.77 | 26.79 | 8.09 | n/a |
Current Ratio | 25.88 | 32.44 | 38.14 | 22.96 | 23.61 | 20.75 | 29.77 | 26.79 | 8.09 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.02 | n/a |
Interest Coverage | n/a | n/a | -56.16 | -255.05 | -334.52 | -314.3 | -270.17 | -268.88 | -137.96 | -4.04K |
Return on Equity | -0.07 | 0.09 | 0.12 | -0.08 | -0.08 | -0.06 | 0.16 | -0.05 | 0.11 | n/a |
Return on Assets | -0.06 | -0.03 | -0.04 | -0.07 | -0.07 | -0.06 | -0.05 | -0.05 | -0.15 | n/a |
Return on Invested Capital | -0.07 | -0.04 | -0.04 | -0.07 | -0.08 | -0.06 | -0.05 | -0.05 | -0.17 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.54 | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.54 | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.38 | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.19 | n/a |